Physician

Elke K Friedman, MD

According to 2025 Medicare claims, Elke Friedman, MD (NPI: 1629073473) practices hematology/oncology in the Richmond, VA market, with the plurality of this provider's patient population coming from Henrico, VA. This provider's primary affiliated billing organization is VIRGINIA CANCER INSTITUTE INCORPORATED (NPI: 1730130980; TIN: 54-1066435) and primary practice location at 23229-8605.

Friedman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 966 traditional Medicare patients, billed 131,870 HCPCS/CPT codes, and received $2,761,946 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,041 prescription claims across 285 beneficiaries totaling $4,131,818 in drug costs, led by Revlimid (Lenalidomide). DME data shows 66 claims. Open Payments data shows 121 records totaling $219,156. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,895,048 to $4,131,818. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,033 to $638.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,196	127,246	$1,993,153
2016	1,238	135,186	$2,549,070
2017	1,281	139,101	$2,365,757
2018	1,226	147,263	$2,207,266
2019	1,166	145,117	$2,694,869
2020	1,140	139,947	$2,783,455
2021	1,082	124,960	$2,669,651
2022	1,141	161,180	$2,896,945
2023	956	156,805	$2,746,472
2024	966	131,870	$2,761,946

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	217	1,385	$1,895,048
2016	235	1,515	$2,077,156
2017	238	1,469	$2,227,375
2018	280	1,576	$2,626,965
2019	259	1,429	$2,898,811
2020	257	1,548	$4,067,671
2021	257	1,791	$3,582,914
2022	281	1,782	$3,595,403
2023	269	1,825	$3,021,055
2024	285	2,041	$4,131,818

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	181	$37,444
2016	42	174	$54,448
2017	38	169	$35,274
2018	N/R	114	$13,658
2019	12	217	$16,114
2020	36	264	$17,396
2021	38	209	$11,227
2022	24	146	$13,294
2023	N/R	77	$12,862
2024	N/R	66	$5,116

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	166	385	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	251	637	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	383	617	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	223	274	$12
96372	Injection of drug or substance under skin or into muscle	154	339	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	56	1,456	$951,936
Tagrisso	Osimertinib Mesylate	54	1,620	$864,757
Imbruvica	Ibrutinib	23	644	$342,985
Pomalyst	Pomalidomide	13	364	$286,550
Ninlaro	Ixazomib Citrate	16	448	$197,661

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$2,248
J8700	Temozolomide, oral, 5 mg	N	N/R	11	$1,239
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	13	$1,071
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	17	$320
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	14	$238

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	119	$2,596	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$216,560	Mirati Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Elke K. Friedman, MD?

Tedicare shows public-source Medicare data for Elke K. Friedman, MD (NPI 1629073473), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elke K. Friedman, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Elke K. Friedman, MD?

Elke K. Friedman, MD is linked to VIRGINIA CANCER INSTITUTE INCORPORATED (billing NPI 1730130980) in the available physician profile data.

Does Elke K. Friedman, MD have Open Payments data?

Elke K. Friedman, MD has 121 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.